Symbol
RNA on Nasdaq
Investment type
Equity / Common Stock
Latest Disclosed Shares Owned
8,515,792 shares
Security Ownership %
5.5%
Shares, Excluding Options vs Price
Value, Excluding Options

Avoro Capital Advisors LLC ownership in Atrium Therapeutics, Inc. Common Stock (RNA)

17 Feb 2026 - Avoro Capital Advisors LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8,515,792 shares of Atrium Therapeutics, Inc. Common Stock (RNA). This represents 5.5% ownership of the company. This is the first filing by Avoro Capital Advisors LLC disclosing ownership of Atrium Therapeutics, Inc. Common Stock (RNA).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.